Is the JN.1 COVID-19 variant more dangerous than we think?
We are much better prepared today than when the epidemic first started.
The JN is highly contagious despite being highly pathogenic. One strain tends to produce mild symptoms similar to the common cold or seasonal flu. Many patients report fever, sore throat, stuffy nose, body aches, and fatigue. Perhaps most important, fatalities, hospitalizations, and serious illness already appear to be less frequent, especially among people who have had prior exposure to the virus or have gotten vaccinated.
This indicates that the severity is being reduced by high levels of community immunity.
Rather than succumb to worry, focus on proactive measures to protect yourself. You also will want to rely on your first line of defense: good old-fashioned hygiene, including washing your hands often and thoroughly, not touching your face, and practicing good respiratory etiquette, which includes coughing and sneezing into your elbow or a tissue.
The well-fitting mask on your face is going to provide an extra degree of protection, especially in an indoor environment with a lot of people or if you're in a high-risk group. It's essential to self-isolate and consider getting tested if you have any symptoms, no matter how mild, to limit the spread of infection. By doing the right thing, you protect yourself and the most vulnerable among us in the community.
Besides antiviral measures, the most important thing is the general health of your body.
Strong immunity requires a diet of nutrient-rich foods, regular exercise, sound sleep, and effective stress management. These natural methods work for promoting your body's natural defenses against all ills.
In short, the surge in infections should raise appropriate concerns but not sound alarms, even if it needs to be talked about. Stay informed, embody healthy behaviors, and remember that the prevention strategies we have been taught and our collective resilience will guide us through this evolving health environment.
Dr Pradeep Narayan Sahoo, Consultant - Internal medicine, Manipal Hospital Bhubaneswar
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
ASHA workers to hold three-day dharna in Bengaluru; demands include better pay and job security
ASHA (Accredited Social Health Activist) workers from BBMP, Bangalore urban and rural districts, will launch a three-day dharna at Freedom Park on Seshadri road, starting August 12, as part of a State-wide agitation demanding better wages and job security. Organised under the umbrella of various ASHA workers' unions, the protest aims to draw the attention of the Karnataka Chief Minister and Health Department to what workers call long-standing neglect of their contributions, especially in the post-pandemic era. Among their primary demands, the ASHA workers are seeking a monthly compensation of ₹10,000, effective from April 2025. This includes both the State-provided honorarium and the Central government's incentive portion. Workers argue that despite being the frontline force in delivering rural healthcare and playing a crucial role during COVID-19, their efforts remain under-recognised and underpaid. The unions have also urged the State government to increase the ₹1,000 honorarium currently provided to all ASHA workers, in line with hikes recently granted to other scheme-based workers in the State Budget. Another key demand is job security. ASHA workers are strongly opposing any move to remove them under the guise of 'rationalisation,' fearing mass displacement and loss of livelihood. Meanwhile, the government has directed the officials to take necessary steps to ensure that public health services are not disrupted. The government issued a circular on Monday instructing the officials of Health and Family Welfare department to convince the ASHA workers of the facilities provided and to persuade them to not participate in the 'illegal agitation'. 'Information about ASHA workers who were absent from duty in their district limits every day from August 12 to 14, 2025, should be submitted to the Commissionerate. Apart from medical emergency, all types of leave should be restricted of all officers and staff of the Health Department (permanent/contract). And, the details of the activities of the ASHA workers who participated in the dharna should be entered on the website,' stated the circular.
News18
an hour ago
- News18
Ousted FDA vaccine chief Vinay Prasad returning to agency
Washington, Aug 11 (AP) A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of President Donald Trump. Dr Vinay Prasad is resuming leadership of the FDA centre that regulates vaccines and biotech therapies, a spokesperson for the Department of Health and Human Services said in a statement Monday. Prasad left the agency late last month after drawing ire of right-wing activists, including Laura Loomer, because of his past statements criticizing Trump. A longtime a critic of FDA's standards for approving medicines, Prasad briefly ordered the maker of a gene therapy for Duchenne's muscular dystrophy to halt shipments after two patient deaths. But that action triggered pushback from the families of boys with the fatal condition and libertarian supporters of increased access to experimental medicines. Prasad's decision to pause the therapy was criticized by The Wall Street Journal editorial board, former Republican Sen Rick Santorum and others. The FDA swiftly reversed its decision suspending the therapy's use. Loomer posted online that Prasad was 'a progressive leftist saboteur," noting his history of praising liberal independent Sen. Bernie Sanders. But Prasad has had the backing of FDA Commissioner Marty Makary and health secretary Robert F Kennedy Jr, who have both called for scrutinizing the use of COVID-19 vaccines. Under Prasad, the FDA restricted the approval of two new COVID-19 shots from vaccine makers Novavax and Moderna and set stricter testing requirements for future approvals. (AP) RD RD view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
2 hours ago
- Time of India
Meet Adam Kovalčík: Teen scientist whose breakthrough could slash the costs of lifesaving drugs for Ebola, COVID-19 and more
Image credits: Getty Images (Representative Image) A 19-year-old from Slovakia was flying to an international science competition in Ohio, with an idea that he didn't expect to win big, but loved enough to showcase to the world. Adam Kovalčík, a teen from a small village in a European country, not only walked away with the George D. Yancopoulos Innovator Award but also a $100,000 top prize for his breakthrough idea that could slash the cost of antiviral drugs. Adam Kovalčík's innovative method Image credits: Getty Images According to a Business Insider report, Kovalčík created a simplified drug production method using corn husks in place of the most costly ingredients. The young prodigy had aimed to make galidesivir cheaper and faster to produce. The drug targets RNA viruses, including Ebola, Zika and COVID-19. He replaced the standard beginning materials with furfuryl alcohol, a compound that is derived from corn waste. Additionally, rather than assembling the molecule in multiple stages, he formed the core sugar in seven reactions, developing a shorter 10-step method from the conventional 15. This cuts the production time from nine to five days and reduces the cost per gram from $75 to just $12.50. What lies ahead? While his method would need to go through clinical trials before any wide-scale applications, the Regeneron judges were impressed and described his presentation as airtight. "This could be a huge step to help prevent some of these RNA viruses," said Chris RoDee, chemist and chair of the judging committee and retired patent examiner. "I cannot describe this feeling," Kovalčík told Business Insider after the live ceremony, adding that he was surprised to win, especially coming from a small Slovakian village. After the competition, he filed a preliminary patent and returned to his university lab to continue refining the synthesis. According to early computer modelling, one new molecule from his work may bind more effectively to viral enzymes than galidesivir. Kovalčík is also working on a side project that turns corn waste into fragrance compounds. His work is a part of a growing movement of scientists who are rethinking food waste to create big breakthroughs from small labs.
